These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25548002)

  • 1. The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer.
    Liu SG; Yuan SH; Wu HY; Liu J; Huang CS
    Cell Biochem Biophys; 2015 May; 72(1):165-9. PubMed ID: 25548002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.
    Hu Y; Hu MM; Shi GL; Han Y; Li BL
    Eur J Surg Oncol; 2014 Sep; 40(9):1136-42. PubMed ID: 24998915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of serum levels of VEGF and TGF-β1 with radiosensitivity of elderly patients with unresectable non-small cell lung cancer.
    Fu ZZ; Gu T; Fu BH; Hua HX; Yang S; Zhang YQ; Gao LM; Li P
    Tumour Biol; 2014 May; 35(5):4785-9. PubMed ID: 24557540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum endostatin correlates with progression and prognosis of non-small cell lung cancer.
    Suzuki M; Iizasa T; Ko E; Baba M; Saitoh Y; Shibuya K; Sekine Y; Yoshida S; Hiroshima K; Fujisawa T
    Lung Cancer; 2002 Jan; 35(1):29-34. PubMed ID: 11750710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.
    Dudek AZ; Mahaseth H
    Cancer Invest; 2005; 23(3):193-200. PubMed ID: 15945504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of circulating transforming growth factor-beta1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancer.
    Zhao L; Ji W; Zhang L; Ou G; Feng Q; Zhou Z; Lei M; Yang W; Wang L
    J Thorac Oncol; 2010 Apr; 5(4):521-5. PubMed ID: 20130485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study.
    Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
    Adv Exp Med Biol; 2013; 788():341-8. PubMed ID: 23835996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.
    Engels EA; Jennings L; Kemp TJ; Chaturvedi AK; Pinto LA; Pfeiffer RM; Trotter JF; Acker M; Onaca N; Klintmalm GB
    Cancer Med; 2015 Aug; 4(8):1252-7. PubMed ID: 25919050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers.
    Li M; Liu F; Sun P; Gao Y; Chen H; Liu H; Wang M; Chen J; Zhao Y
    Hepatogastroenterology; 2012 Sep; 59(118):1865-8. PubMed ID: 22819906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum angiopoietin-2 as a clinical marker for lung cancer.
    Park JH; Park KJ; Kim YS; Sheen SS; Lee KS; Lee HN; Oh YJ; Hwang SC
    Chest; 2007 Jul; 132(1):200-6. PubMed ID: 17505039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
    Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
    Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
    Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
    Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
    Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
    Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
    Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
    Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients.
    Fu BH; Fu ZZ; Meng W; Gu T; Sun XD; Zhang Z
    Tumour Biol; 2015 Aug; 36(8):6477-83. PubMed ID: 25820820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of endostatin and VEGF in non-small cell lung cancer patients and the relationship with the clinical pathophysiological characteristics].
    Liu Y; Zhou Q; Lu Y; Zhu W; Wang Y; Zhang J; Liu L; Sun Z
    Zhongguo Fei Ai Za Zhi; 2004 Feb; 7(1):50-4. PubMed ID: 21211193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
    Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
    Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients.
    Wang S; Han X; Hu X; Wang X; Zhao L; Tang L; Feng Y; Wu D; Sun Y; Shi Y
    Clin Chim Acta; 2014 Mar; 430():63-70. PubMed ID: 24378285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.